Bowmer C J, Donoghue P G, Leong C F, Yates M S
J Pharm Pharmacol. 1985 Nov;37(11):812-5. doi: 10.1111/j.2042-7158.1985.tb04974.x.
Chenodeoxycholic, cholic, deoxycholic and taurodeoxycholic acids were found to inhibit the binding of 2-(4'-hydroxybenzeneazo)benzoic acid, methyl orange, sulphadimethoxine and warfarin to human albumin. In addition, glycodeoxycholic acid inhibited the binding of sulphadimethoxine and warfarin. In contrast, these bile acids did not inhibit the binding of phenylbutazone. The extent of displacement was in the rank order of: dihydroxy acids (chenodeoxycholic and deoxycholic) greater than trihydroxy acid (cholic) greater than conjugates (glycodeoxycholic and taurodeoxycholic). Thus the introduction of polar groups into the steroid nucleus of bile acids reduces their effectiveness as binding inhibitors. Displacement was usually accompanied by a decrease in the apparent association constant which suggests that the mechanism of displacement may be competitive.
发现鹅去氧胆酸、胆酸、脱氧胆酸和牛磺脱氧胆酸可抑制2-(4'-羟基苯偶氮)苯甲酸、甲基橙、磺胺二甲氧嘧啶和华法林与人白蛋白的结合。此外,甘氨脱氧胆酸可抑制磺胺二甲氧嘧啶和华法林的结合。相比之下,这些胆汁酸并不抑制保泰松的结合。置换程度的顺序为:二羟基酸(鹅去氧胆酸和脱氧胆酸)大于三羟基酸(胆酸)大于共轭物(甘氨脱氧胆酸和牛磺脱氧胆酸)。因此,在胆汁酸的甾体核中引入极性基团会降低其作为结合抑制剂的效力。置换通常伴随着表观缔合常数的降低,这表明置换机制可能是竞争性的。